Renaissance Technologies (RenTech)'s JBIO Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 73,591 shares of Jade Biosciences, Inc. (JBIO) worth $1.64 M, representing 0.00% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in JBIO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 65,438 shares. Largest reduction occurred in Q2 2026, reducing 61,448 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Jade Biosciences (JBIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Jade Biosciences (JBIO) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -61,448 | Reduce 45.50% | 73,591 | $22.22 |
| Q1 2026 | +65,438 | Add 94.02% | 135,039 | $14.05 |
| Q4 2025 | +69,601 | New Buy | 69,601 | $15.43 |
Renaissance Technologies (RenTech)'s Jade Biosciences Investment FAQs
Renaissance Technologies (RenTech) first purchased Jade Biosciences, Inc. (JBIO) in Q4 2025, acquiring 69,601 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Jade Biosciences, Inc. (JBIO) for 3 quarters since Q4 2025.
Renaissance Technologies (RenTech)'s largest addition to Jade Biosciences, Inc. (JBIO) was in Q4 2025, adding 69,601 shares worth $1.07 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 73,591 shares of Jade Biosciences, Inc. (JBIO), valued at approximately $1.64 M.
As of the Q2 2026 filing, Jade Biosciences, Inc. (JBIO) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Jade Biosciences, Inc. (JBIO) was 135,039 shares, as reported at the end of Q1 2026.